title: Sequence-specific stalling of DNA polymerase γ and the effects of mutations causing progressive ophthalmoplegia.
abstract: A large number of mutations in the gene encoding the catalytic subunit of mitochondrial DNA polymerase γ (POLγA) cause human disease. The Y955C mutation is common and leads to a dominant disease with progressive external ophthalmoplegia and other symptoms. The biochemical effect of the Y955C mutation has been extensively studied and it has been reported to lower enzyme processivity due to decreased capacity to utilize dNTPs. However, it is unclear why this biochemical defect leads to a dominant disease. Consistent with previous reports, we show here that the POLγA:Y955C enzyme only synthesizes short DNA products at dNTP concentrations that are sufficient for proper function of wild-type POLγA. In addition, we find that this phenotype is overcome by increasing the dNTP concentration, e.g. dATP. At low dATP concentrations, the POLγA:Y955C enzyme stalls at dATP insertion sites and instead enters a polymerase/exonuclease idling mode. The POLγA:Y955C enzyme will compete with wild-type POLγA for primer utilization, and this will result in a heterogeneous population of short and long DNA replication products. In addition, there is a possibility that POLγA:Y955C is recruited to nicks of mtDNA and there enters an idling mode preventing ligation. Our results provide a novel explanation for the dominant mtDNA replication phenotypes seen in patients harboring the Y955C mutation, including the existence of site-specific stalling. Our data may also explain why mutations that disturb dATP pools can be especially deleterious for mtDNA synthesis.
authors.affiliation: Division of Metabolic Diseases, Karolinska Institutet, Solna, SE-17177 Stockholm, Sweden.
authors.forename: Neli
authors.initials: N
authors.lastname: Atanassova
authors.forename: Javier Miralles
authors.initials: JM
authors.lastname: Fusté
authors.forename: Sjoerd
authors.initials: S
authors.lastname: Wanrooij
authors.forename: Bertil
authors.initials: B
authors.lastname: Macao
authors.forename: Steffi
authors.initials: S
authors.lastname: Goffart
authors.forename: Stefan
authors.initials: S
authors.lastname: Bäckström
authors.forename: Geraldine
authors.initials: G
authors.lastname: Farge
authors.forename: Ivan
authors.initials: I
authors.lastname: Khvorostov
authors.forename: Nils-Göran
authors.initials: NG
authors.lastname: Larsson
authors.forename: Johannes N
authors.initials: JN
authors.lastname: Spelbrink
authors.forename: Maria
authors.initials: M
authors.lastname: Falkenberg
mesh_terms: D002460:Cell Line; D000074002:DNA Polymerase gamma; D004261:DNA Replication; D004272:DNA, Mitochondrial / Q000235:genetics; D004259:DNA-Directed DNA Polymerase / Q000235:genetics* / Q000378:metabolism*; D006801:Humans; D020125:Mutation, Missense; D017246:Ophthalmoplegia, Chronic Progressive External / Q000201:enzymology* / Q000235:genetics
chemical_list: D004272:DNA, Mitochondrial; D000074002:DNA Polymerase gamma; D004259:DNA-Directed DNA Polymerase